Metraipolis › archive › dc_05f4803f2ed3

Agomelatine — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Agomelatine
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-07T19:40:20.125Z
SHA-256 of the archived text
f99a8e1acf9202de1d1ff1dc769a0028955528851cab4141e53633fa25a1d514
Stable URL of this page
https://metraipolis.com/documento/dc_05f4803f2ed3

How to cite

Agomelatine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Agomelatine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_05f4803f2ed3 (Metraipolis archive dc_05f4803f2ed3, sha256 f99a8e1acf9202de1d1ff1dc769a0028955528851cab4141e53633fa25a1d514)
BibTeX
@misc{dc05f4803f2ed3,
  title = {Agomelatine — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Agomelatine},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_05f4803f2ed3; sha256 f99a8e1acf9202de1d1ff1dc769a0028955528851cab4141e53633fa25a1d514},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Agomelatine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Agomelatine, sold under the brand name Thymanax among others, is an atypical antidepressant most commonly used to treat major depressive disorder and generalized anxiety disorder. One review found that it is as effective as other antidepressants with similar discontinuation rates overall but fewer discontinuations due to side effects. Another review also found it was similarly effective to many other antidepressants. Common side effects include headaches, nausea, and dizziness, which usually subside in the first few weeks, as well as liver problems – due to the potential effect on the liver, blood tests before treatment initiation, at specific time-points after initiation, and after dose increase is recommended. Its use is not recommended in people with dementia, or who are under the age of 18 or over 75. There is tentative evidence that it may have fewer side effects than some other antidepressants. It acts by blocking certain serotonin receptors and activating melatonin receptors. Agomelatine was authorized for medical use in the European Union in 2009 and Australia in 2010. Its use in the United States is not approved. It was developed by the pharmaceutical company Servier.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Agomelatine» — https://en.wikipedia.org/wiki/Agomelatine
Wikidata Q395229: «farmaco» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q395229
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Agomelatine?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1366468764, consultata il 2026-11-07T19:37:00.369Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 304bb6d5706ccf986e7fb5195ed76878c962945fb2162850d7d08dd54d6f01ac